• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Packages of Mifepristone tablets are displayed at a family planning clinic on April 13, 2023, in Rockville, Maryland. A Massachusetts appeals court temporarily blocked a Texas-based federal judge’s ruling that suspended the FDA’s approval of the abortion drug Mifepristone, which is part of a two-drug regimen to induce an abortion in the first trimester of pregnancy in combination with the drug Misoprostol.
    Healthcare

    Why Big Pharma sees the abortion drug legal fight as a grave business risk

    Kaelan Deese -
    May 4, 2023 11:00 am
    0
    How to restore and reshore vital medications
    Beltway Confidential

    How to restore and reshore vital medications

    Marion Mass, Nikki Johnson -
    May 3, 2023 6:00 am
    0
    Pharmacy benefit managers are picking patients’ pockets
    Beltway Confidential

    Pharmacy benefit managers are picking patients’ pockets

    Sally Pipes -
    April 3, 2023 6:00 am
    0
    Medicare trust fund to be exhausted in 2031, trustees project
    Community and Family

    Medicare trust fund to be exhausted in 2031, trustees project

    Zach Halaschak -
    March 31, 2023 11:45 am
    0
    Pharmacies face lawsuits and protests if they dispense abortion pills
    Business

    Pharmacies face lawsuits and protests if they dispense abortion pills

    Abigail Adcox -
    March 21, 2023 9:30 am
    0
    Insulin can cost an uninsured patient between $120 to $400 per month. By comparison, some generics would only cost about $4. (AP Photo)
    Healthcare

    The top three insulin makers now charge only $35 a month for privately insured

    Abigail Adcox -
    March 17, 2023 3:19 pm
    0
    FILE - In this May 18, 2017 file photo, the Healthcare.gov website is seen on a laptop computer, in Washington. Former Obama administration officials say they're launching a private campaign to encourage people to sign up for coverage next year under the Affordable Care Act. With the start of open enrollment just weeks away on Nov. 1, the Trump administration has slashed "Obamacare's" ad budget, as well as grants to outside organizations that are supposed to help consumers sign up.
    Beltway Confidential

    Congress doesn’t have to fix the health insurance industry, but it can help us work around it

    Tiana Lowe Doescher -
    March 17, 2023 10:55 am
    0
    Prescription drug middlemen are jacking up prices
    Beltway Confidential

    Prescription drug middlemen are jacking up prices

    B. Douglas Hoey -
    March 17, 2023 6:00 am
    0
    Republicans and Democrats eye drug pricing reform in new Congress
    Fairness and Justice

    Republicans and Democrats eye drug pricing reform in new Congress

    Abigail Adcox -
    March 16, 2023 7:12 am
    0
    WATCH LIVE: Biden delivers speech on efforts to lower prescription drug costs
    Healthcare

    WATCH LIVE: Biden delivers speech on efforts to lower prescription drug costs

    Rachel Schilke -
    March 15, 2023 5:30 pm
    0
    1...272829...157Page 28 of 157
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.